- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on Adenocarcinoma of Prostate in New Zealand
Total 5085 results
-
NCIC Clinical Trials GroupCompletedQuality of Life | Pain | Prostate CancerCanada
-
Duke UniversityAstellas Pharma Inc; Medivation, Inc.CompletedProstate CancerUnited States
-
Duke UniversitySanofi; PfizerTerminated
-
EMD SeronoCompletedProstate Cancer MetastaticUnited States, Australia, France, Poland, Russian Federation, Spain, Germany, Netherlands, Slovakia, Canada, South Africa, Belgium
-
Corcept TherapeuticsCompletedMetastatic Castration-Resistant Prostate CancerUnited States, United Kingdom
-
Royal North Shore HospitalRecruitingLocally Recurrent Prostate CancerAustralia
-
Sidney Kimmel Comprehensive Cancer Center at Johns...Clovis Oncology, Inc.Active, not recruitingProstate Cancer MetastaticUnited States
-
Carolina Research Professionals, LLCAstellas Pharma IncCompletedProstate Carcinoma Metastatic to the BoneUnited States
-
Montefiore Medical CenterAlbert Einstein College of MedicineActive, not recruitingProstate CancerUnited States
-
OncoC4, Inc.Prostate Cancer Clinical Trials ConsortiumRecruitingMetastatic Castration-resistant Prostate CancerUnited States
-
Exosome Diagnostics, Inc.Terminated
-
Icahn School of Medicine at Mount SinaiCompleted
-
Memorial Sloan Kettering Cancer CenterJohns Hopkins University; M.D. Anderson Cancer Center; Mayo Clinic; Baylor College... and other collaboratorsCompleted
-
MEI Pharma, Inc.CompletedProstate CancerUnited States
-
Janssen Research & Development, LLCRecruitingAdvanced Prostate CancerFrance, United States
-
Memorial Sloan Kettering Cancer CenterGlaxoSmithKline; University of WashingtonCompletedProstate Cancer | Castration-resistant, MetastaticUnited States
-
Rutgers, The State University of New JerseyBristol-Myers Squibb; National Cancer Institute (NCI)CompletedProstate CancerUnited States
-
Weill Medical College of Cornell UniversityCompletedProstate CancerUnited States
-
Bristol-Myers SquibbCompletedProstate CancerUnited States
-
Mark SteinRecruitingRecurrent Prostate CancerUnited States
-
VA Office of Research and DevelopmentSanofiCompletedProstate CancerUnited States, Puerto Rico
-
VA Office of Research and DevelopmentRecruitingRecurrent Prostate Cancer | Prostate Cancer | Metastatic Prostate Cancer | Oligometastasis | Oligorecurrence | De Novo Prostate CancerUnited States
-
Astellas Pharma IncCompletedMetastatic Castration Resistant Prostate CancerIndia
-
University of SydneyTrans Tasman Radiation Oncology GroupUnknownProstate CancerAustralia
-
Barbara Ann Karmanos Cancer InstituteNational Cancer Institute (NCI)Completed
-
Memorial Sloan Kettering Cancer CenterUniversity of California, Los Angeles; Ferring Pharmaceuticals; Wayne State University and other collaboratorsCompleted
-
Memorial Sloan Kettering Cancer CenterNational Cancer Institute (NCI)CompletedProstate CancerUnited States
-
Memorial Sloan Kettering Cancer CenterNational Cancer Institute (NCI)Completed
-
Memorial Sloan Kettering Cancer CenterNational Cancer Institute (NCI)CompletedProstate CancerUnited States
-
Memorial Sloan Kettering Cancer CenterNational Cancer Institute (NCI)CompletedProstate CancerUnited States
-
Weill Medical College of Cornell UniversityCompletedProstate CancerUnited States
-
Hinova Pharmaceuticals Aus Pty LtdCompletedMetastatic Castration-resistant Prostate CancerAustralia
-
Progenics Pharmaceuticals, Inc.Completed
-
American College of Radiology Imaging NetworkNational Cancer Institute (NCI)Completed
-
Veru Inc.CompletedProstate Cancer MetastaticUnited States
-
Amunix, a Sanofi CompanyRecruitingHormone-refractory Prostate CancerAustralia, Spain, United Kingdom
-
Yale UniversityNational Cancer Institute (NCI)RecruitingStage IV Prostate Adenocarcinoma AJCC v7United States, Taiwan, Korea, Republic of, Australia, China, Japan
-
Millennium Pharmaceuticals, Inc.CompletedProstate CancerUnited States
-
Memorial Sloan Kettering Cancer CenterCompleted
-
Herbert Irving Comprehensive Cancer CenterUnknownProstate CancerUnited States
-
Memorial Sloan Kettering Cancer CenterNational Cancer Institute (NCI)Completed
-
Memorial Sloan Kettering Cancer CenterCompleted
-
Memorial Sloan Kettering Cancer CenterNational Cancer Institute (NCI)Completed
-
Memorial Sloan Kettering Cancer CenterNational Cancer Institute (NCI)Completed
-
Memorial Sloan Kettering Cancer CenterNational Cancer Institute (NCI)CompletedProstate CancerUnited States
-
NYU Langone HealthNational Cancer Institute (NCI)CompletedProstate CancerUnited States
-
GenomeDx Biosciences CorpColumbia UniversityCompleted
-
Molecular Insight Pharmaceuticals, Inc.Completed
-
Sumitomo Pharma Switzerland GmbHActive, not recruitingMetastatic Castration-Resistant Prostate Cancer | Metastatic Castration-Sensitive Prostate Cancer | Non-Metastatic Castration-Resistant Prostate CancerUnited States